|
Volumn 41, Issue 1-2, 2001, Pages 57-63
|
Quantitative determination of 3,3′-diindolylmethane in urine of individuals receiving indole-3-carbinol
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 INDOLEMETHANOL;
3,3' DIINDOLYLMETHANE;
3,3'-DIINDOLYLMETHANE;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
INDOLE-3-CARBINOL;
PLACEBO;
BIOCHEMICAL MARKER;
DRUG METABOLITE;
UNCLASSIFIED DRUG;
ARTICLE;
FEMALE;
HALF LIFE TIME;
HUMAN;
MASS FRAGMENTOGRAPHY;
SENSITIVITY AND SPECIFICITY;
URINE;
UTERINE CERVIX CARCINOMA IN SITU;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER RISK;
CORRELATION ANALYSIS;
DOSE RESPONSE;
DRUG DETERMINATION;
DRUG RESPONSE;
DRUG URINE LEVEL;
GAS CHROMATOGRAPHY;
INGESTION;
MASS SPECTROMETRY;
PATIENT COMPLIANCE;
URINALYSIS;
UTERINE CERVIX DYSPLASIA;
ANTICARCINOGENIC AGENTS;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
FEMALE;
GAS CHROMATOGRAPHY-MASS SPECTROMETRY;
HALF-LIFE;
HUMANS;
INDOLES;
PLACEBOS;
SENSITIVITY AND SPECIFICITY;
HUMAN;
MASS FRAGMENTOGRAPHY;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
|
EID: 0035527478
PISSN: 01635581
EISSN: None
Source Type: Journal
DOI: 10.1080/01635581.2001.9680612 Document Type: Article |
Times cited : (35)
|
References (26)
|